Vaxcyte
PCVX
PCVX
125 hedge funds and large institutions have $1.45B invested in Vaxcyte in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
+19
Holders Change %
+17.92%
% of All Funds
2.16%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.09%
New
26
Increased
50
Reduced
27
Closed
7
Calls
$7.95M
Puts
$13.6M
Net Calls
-$5.64M
Net Calls Change
-$11M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GTCM
126
Gyon Technologies Capital Management
Denville,
New Jersey
| – | -$590K | -27,105 | Closed |
|
|
BFM
127
Boothbay Fund Management
New York
| – | -$495K | -22,733 | Closed |
|
|
TI
128
Trexquant Investment
Stamford,
Connecticut
| – | -$367K | -16,851 | Closed |
|
129
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$301K | -13,820 | Closed |
|
130
Voloridge Investment Management
Jupiter,
Florida
| – | -$271K | -12,475 | Closed |
|